Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 44,500
+2,400 (5.70%)
Aug 28, 2026, 3:30 PM KST
Hanmi Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,408,098 | 1,356,958 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 |
| 1,408,098 | 1,356,958 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 | |
Revenue Growth | 10.00% | 5.73% | 2.85% | 19.30% | 10.09% | 10.82% |
Cost of Revenue | 1,074,749 | 1,045,650 | 1,015,152 | 986,452 | 886,360 | 1,673 |
Gross Profit | 333,349 | 311,308 | 268,280 | 261,455 | 159,694 | 948,491 |
Selling, General & Admin | 256,997 | 244,862 | 220,611 | 195,711 | 126,104 | 914,482 |
Operating Expenses | 266,328 | 254,343 | 230,322 | 204,443 | 131,583 | 919,739 |
Operating Income | 67,021 | 56,964 | 37,958 | 57,012 | 28,112 | 28,753 |
Interest Expense | -9,866 | -10,570 | -11,346 | -10,161 | -3,689 | -1,794 |
Interest & Investment Income | 2,002 | 1,989 | 1,524 | 643.37 | 164.12 | 94.61 |
Earnings From Equity Investments | 115,991 | 81,763 | 60,910 | 84,501 | 39,514 | 24,234 |
Currency Exchange Gain (Loss) | 1,806 | 1,625 | 853.74 | -19.9 | 425.09 | -285.85 |
Other Non Operating Income (Expenses) | 1,481 | 2,995 | -16,694 | -735.98 | 8,901 | -1,791 |
EBT Excluding Unusual Items | 178,435 | 134,766 | 73,207 | 131,240 | 73,426 | 49,211 |
Gain (Loss) on Sale of Investments | -1,668 | -1,760 | 402.35 | -3.33 | -2.71 | -41.85 |
Gain (Loss) on Sale of Assets | 2.14 | 3.92 | 10.9 | -37.88 | 23.48 | 1.33 |
Asset Writedown | -6.29 | -6.29 | -10,525 | -656.65 | -267.48 | -48.21 |
Pretax Income | 176,763 | 133,003 | 63,095 | 130,542 | 73,180 | 49,122 |
Income Tax Expense | 25,875 | 15,294 | 6,402 | 15,422 | 4,144 | 6,182 |
Earnings From Continuing Operations | 150,888 | 117,709 | 56,693 | 115,120 | 69,035 | 42,940 |
Minority Interest in Earnings | 26.93 | 660.75 | 2,729 | 1.65 | 174.26 | 2.07 |
Net Income | 150,915 | 118,370 | 59,422 | 115,122 | 69,210 | 42,942 |
Net Income to Common | 150,915 | 118,370 | 59,422 | 115,122 | 69,210 | 42,942 |
Net Income Growth | 148.85% | 99.20% | -48.38% | 66.34% | 61.17% | 90.00% |
Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 68 | 69 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 68 | 69 |
Shares Change | 0.21% | 0.11% | -0.41% | -0.79% | -0.18% | -0.02% |
EPS (Basic) | 2228.14 | 1748.09 | 878.00 | 1694.06 | 1010.45 | 625.80 |
EPS (Diluted) | 2226.79 | 1747.00 | 878.00 | 1694.06 | 1010.45 | 625.80 |
EPS Growth | 148.32% | 98.98% | -48.17% | 67.66% | 61.47% | 90.04% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 27,851 | 28,730 | 73,154 | 28,228 | 2,054 | 11,874 |
Free Cash Flow Per Share | 410.96 | 424.05 | 1080.90 | 415.38 | 29.99 | 173.04 |
Gross Margin | 23.67% | 22.94% | 20.90% | 20.95% | 15.27% | 99.82% |
Operating Margin | 4.76% | 4.20% | 2.96% | 4.57% | 2.69% | 3.03% |
Profit Margin | 10.72% | 8.72% | 4.63% | 9.22% | 6.62% | 4.52% |
Free Cash Flow Margin | 1.98% | 2.12% | 5.70% | 2.26% | 0.20% | 1.25% |
EBITDA | 76,352 | 66,445 | 47,669 | 65,744 | 33,590 | 34,009 |
EBITDA Margin | 5.42% | 4.90% | 3.71% | 5.27% | 3.21% | 3.58% |
D&A For EBITDA | 9,331 | 9,481 | 9,711 | 8,732 | 5,478 | 5,257 |
EBIT | 67,021 | 56,964 | 37,958 | 57,012 | 28,112 | 28,753 |
EBIT Margin | 4.76% | 4.20% | 2.96% | 4.57% | 2.69% | 3.03% |
Effective Tax Rate | 14.64% | 11.50% | 10.15% | 11.81% | 5.66% | 12.58% |
Advertising Expenses | - | 19,551 | 15,017 | 12,222 | 7,083 | 5,389 |